This is a preview and has not been published.

Simultaneous Determination of Piroxicam and Codeine Phosphate Hemihydrate in a Pharmaceutical Dosage Form Using Validated HPLC Method


  • Ammar Alsaqqa Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Damascus University, Damascus, Syria.
  • Jameela A. Hasian Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Damascus University, Damascus, Syria.
  • Anton M. Al-Laham Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Damascus University, Damascus, Syria.



Codeine Phosphate, HPLC, Piroxicam, System Suitability Test, Validation


An easy, eclectic, precise high-Performance Liquid Chromatographic (HPLC) procedure was evolved and validated to estimate of Piroxicam and Codeine phosphate. Chromatographic demarcation was accomplished on a C18 column [Use BDS Hypersil C18, 5μ, 150 x 4.6 mm] using a mobile phase of methanol: phosphate buffer (60:40, v/v, pH=2.3), the flow rate was 1.1 mL/min, UV detection was at 214 nm. System Suitability tests (SSTs) are typically performed to assess the suitability and effectiveness of the entire chromatography system. The retention time for Piroxicam was found to be 3.95 minutes and 1.46 minutes for Codeine phosphate. The evolved method has been validated through precision, limit of quantitation, specificity, limit of detection linearity and accuracy. (LOD) was 1.92 mg/mL and (LOQ) was 6.336 mg/mL for Piroxicam, whereas (LOD) for Codeine phosphate was 0.29 mg/mL and (LOQ) was 0.95 mg/mL. Piroxicam and Codeine phosphate showed a linear signal in the domain of 5-50 µg/mL for each compound. This research presided to evolve and validate an HPLC method, and the proposed procedure can be used to estimate these drugs in their combined dosage forms.


Download data is not yet available.


Diaf K, Elbahri Z, Besbes N. PiroxicamI Based Microspheres: An overview of new formulations for the drug-controlled release. Moroc. J Heterocycl Chem.2021; 20(1):40-48.

Shohin IE, Kulinich JI, Ramenskaya G v, Abrahamsson B, Kopp S, Langguth P, et al. Biowaiver monographs for immediate release solid oral dosage forms: piroxicam. J pharm sci. 2014;103(2):367-377.

Sweetman, SC. (2009). Martindale. 36th Edition. London: UK. Pharmaceutical Press. p: 1-117.

Dahan A, Wolk O, Zur M, Amidon GL, Abrahamsson B, Cristofoletti R, et al. Biowaiver monographs for immediate-release solid oral dosage forms: Codeine phosphate. J Pharm Sci. 2014;103(6):1592-1600.

Bhyan B, Bhatt DC, Jangra S, Prahakar E. Method Development and Validation for Simultaneous Estimation of Zolmitriptan and Piroxicam by UV Spectrophotometric Method. Gradiva Rev J. 2021;7(10):160-167.

Prabhu PP, Das P, Tari A. Development of cleaning method validation techniques piroxicam and telmisartan. Indian Drugs. 2021; 58(8): 49-53.

Iqbal MS, Akhtar Shah P, Khan T, et al. Rapid Analytical Method Development and Validation of Combined Tablet of Drotaverine Hydrochloride and Piroxicam. Asian J. Pharm. 2021;15(1):100-105.

Singh S, Patel JR, Kare S. Estimation of piroxicam in tablet dosage form by using UV-Vis. spectrophotometer. Asian J. Chem. 2016;9(2):82.

Abdulkarim MF, Abdullah GZ, Sakeena MH, Chitneni M, Yam MF, Mahdi ES, Salman IM, Ameer OZ, Sattar MA, Basri M, Noor AM. Modification and validation of an HPLC method for quantification of piroxicam. Int. J. Drug Deliv. 2011 Jan 1;3(1).

Khan IU, Ashfaq M, Razzaq SN, Mariam I. Simultaneous determination of piroxicam and paracetamol in pharmaceutical formulations using stability indicating HPLC method.

J. Liq. Chromatogr. Relat. Technol. 2013;36(10):1437-1450.

Dragomiroiu G, Cimpoiesu A, Ginghina O, Baloescu C, Barca M, Popa D, et al. The development and validation of a rapid HPLC method for determination of piroxicam. Farmacia. 2015;63(1):123-131.

Singh SN, Patil UK. Estimation of non-micronized piroxicam in SEDDS formulation by HPLC method. drugs. 2014; 11:12.

Otarola J, Lista AG, Fernández Band B, Garrido M. Capillary electrophoresis to determine entrapment efficiency of a nanostructured lipid carrier loaded with piroxicam. J. Pharm. Anal. 2015;5(1):70-73.

Pratiwi R, Noviana E, Fauziati R, Fauziati R, Carrao D, Gandhi F, et al. A Review of Analytical Methods for Codeine Determination. Molecules. 2021;26(4):800.

The United States Pharmacopeial Convention. USP Monograph Chapter. Piroxicam. The United States Pharmacopeia and The National Formulary. USP 43–NF 38. Rockville, MD: The United States Pharmacopeial Convention, 2020. p: 3577.

Bulduk İ. HPLC-UV method for quantification of favipiravir in pharmaceutical formulations. Acta Chromatogr. 2021;33(3):209-215.

Bose A. HPLC calibration process parameters in terms of system suitability test. Austin Chromatogr. 2014;1(2):1-4.

Kavittha KY, Geetha G, Venkatnarayanan R. Development and validation of liquid chromatographic methods for the estimation of drugs in multi-component dosage forms. Pharm. Glob. 2012 Nov 1;3(11):1.

Tiwari P, Singh BK. HPLC: a modern approach of development and validation. World J Pharm Res. 2016 Jul 18; 5:1616-31.

IFPMA I. validation of analytical procedures: text and methodology Q2 (R1). International Conference on Harmonization, Geneva, Switzerland 2005.

Vidushi Y, Meenakshi B. A review on HPLC method development and validation. Res J Life Sci, Bioinform, Pharm Chem Sci. 2017;2(6):178.

Luxminarayan L, Sharma N, Viswas A, Khinchi MP. A review on chromatography techniques. Asian J. Pharm. Res. Dev. 2017 Mar 1:1-08.

Rina R, Baile M, Jain A. A Review: Analytical Method Development and Validation. Syst. Rev. Pharm. 2021 Jun 11;12(11):3601-5.

Ahmed NR. High performance liquid chromatographic method for the determination of guaifenesin in pharmaceutical syrups and in environmental samples. Baghdad Sci. J. 2013;10(3).

Jassim SA, Mahmood JM, Imran NA, Ali AS. Optimum conditions for ascorbic acid determination in three Iraqi citrus using HPLC technique. Baghdad Sci. J. 2014; 11:3.